Evidence map›Paper›PMID 42744275›Full record

ArticleVirus research2026

Tracing the patterns of HIV-1 transmission among people with different diagnosis status in Greece.

Evangelia Georgia Kostaki, Stefanos Limnaios, Georgios Adamis, Georgios Xylomenos, Maria Chini, Nikos Mangafas, Marios Lazanas, Stavros Patrinos, Simeon Metallidis, Olga Tsachouridou and 27 more

Abstract read
In one paragraph

Article in Virus research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

37 authors.

Evangelia Georgia KostakiDepartment of Preventive Medicine, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Stefanos LimnaiosDepartment of Preventive Medicine, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Georgios Adamis1st Department of Internal Medicine, G. Genimatas General Hospital, Athens, Greece.
Georgios Xylomenos1st Department of Internal Medicine, G. Genimatas General Hospital, Athens, Greece.
Maria Chini3rd Department of Internal Medicine-Infectious Diseases Unit, "Korgialeneio-Benakeio" Red Cross General Hospital, Athens, Greece.
Nikos Mangafas3rd Department of Internal Medicine-Infectious Diseases Unit, "Korgialeneio-Benakeio" Red Cross General Hospital, Athens, Greece.
Marios Lazanas3rd Department of Internal Medicine-Infectious Diseases Unit, "Korgialeneio-Benakeio" Red Cross General Hospital, Athens, Greece.
Stavros PatrinosNational Public Health Organization, Marousi, Greece.
Simeon Metallidis1st Department of Internal Medicine, AHEPA University Hospital, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Olga Tsachouridou1st Department of Internal Medicine, AHEPA University Hospital, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Vasileios Papastamopoulos5th Department of Internal Medicine and Infectious Diseases, Evaggelismos General Hospital, Athens, Greece.
Dimitrios ChatzidimitriouNational AIDS Reference Centre of Northern Greece, Department of Microbiology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Anastasia Antoniadou4th Department of Internal Medicine, Αttikon University General Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Antonios Papadopoulos4th Department of Internal Medicine, Αttikon University General Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Konstantinos Protopapas4th Department of Internal Medicine, Αttikon University General Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Chrysa TsiaraNational Public Health Organization, Marousi, Greece.
Mina Psichogiou1st Department of Internal Medicine, Laiko General Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Dimitrios Basoulis1st Department of Internal Medicine, Laiko General Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Dimitrios PilalasNational AIDS Reference Centre of Northern Greece, Department of Microbiology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Dimitra ParaskevaDepartment of Internal Medicine, Tzaneio General Hospital, Piraeus, Greece.
Georgios ChrysosDepartment of Internal Medicine, Tzaneio General Hospital, Piraeus, Greece.
Vasileios PaparizosHIV/AIDS Unit, A. Syngros Hospital of Dermatology and Venereology, Athens, Greece.
Sofia KourkountiHIV/AIDS Unit, A. Syngros Hospital of Dermatology and Venereology, Athens, Greece.
Helen SambatakouHIV Unit, 2nd Department of Internal Medicine, Hippokration University General Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Vasileios BolanosHIV Unit, 2nd Department of Internal Medicine, Hippokration University General Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Nikolaos V SipsasDepartment of Pathophysiology, Laiko General Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Malvina Lada2nd Department of Internal Medicine, Sismanogleio General Hospital, Athens, Greece.
Emmanouil BarbounakisDepartment of Internal Medicine, University Hospital of Heraklion "PAGNI", Medical School, University of Crete, Heraklion, Greece.
Evrikleia KantzilakiDepartment of Internal Medicine, University Hospital of Heraklion "PAGNI", Medical School, University of Crete, Heraklion, Greece.
Periklis Panagopoulos2nd Department of Internal Medicine, University General Hospital of Alexandroupolis, Democritus University of Thrace, Alexandroupolis, Greece.
Vasilis Petrakis2nd Department of Internal Medicine, University General Hospital of Alexandroupolis, Democritus University of Thrace, Alexandroupolis, Greece.
Stelios DrimisDepartment of Internal Medicine, Tzaneio General Hospital, Piraeus, Greece.
Pagona LagiouDepartment of Preventive Medicine, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Angelos HatzakisDepartment of Preventive Medicine, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Lemonia SkouraNational AIDS Reference Centre of Northern Greece, Department of Microbiology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Gkikas MagiorkinisDepartment of Preventive Medicine, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Dimitrios ParaskevisDepartment of Preventive Medicine, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, Athens, Greece. Electronic address: dparask@med.uoa.gr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Late presentation remains a major hurdle for HIV management and prevention. We investigated the potential source of transmission among people living with HIV (PLHIV) with different stages of diagnosis, using a combined approach of the traditional definition of late presentation (CD4-based) and the estimated time between HIV acquisition and diagnosis. The study included 3,093 HIV-1 subtype A1 and B sequences from a period with dense sampling in Greece. HIV acquisition dates were estimated using molecular clock analysis and transmissions patterns were assessed with a modified phylogeographic approach. For subtype A1, analysis using the estimated time from HIV acquisition to diagnosis revealed that among PLHIV with recent diagnosis, the mean number of infections originating from PLHIV with late and intermediate diagnosis, were 35.7 (11%) and 32.8 (10.2%), respectively. For those diagnosed late, 21.3 (6.7%) and 18.5 (5.8%) infections (mean number) were from PLHIV with intermediate and recent diagnosis, respectively. Similarly for subtype B, a considerable proportion of infections among PLHIV with recent (12.2%) and intermediate (13.1%) diagnoses originated from PLHIV with late status. Statistical phylogeography confirmed that late presenters were a significant source of transmission to PLHIV in other diagnosis-status categories for both subtypes. Analysis using CD4 cell count showed that late presentation and advanced disease groups provided a significant source of transmission to other groups. Our study highlights that early diagnosis, besides the beneficial effect for the disease prognosis, would significantly mitigate onward HIV transmission. This underscores the need to enhance HIV testing strategies in Greece to ensure earlier diagnosis and timely treatment initiation.

Indexed as

Diagnosis statusGreeceHIVInfection dateLate presentationMolecular epidemiologyPhylogeography

Identifiers

PMID42744275
PMCPMC13627126

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.